Stock Taper
SCREENER COMPARE ANY 2 STOCKS
RDY
DR. REDDY'S LABORATORIES LIMITED
NYSE
$12.18
▲ UP 0.16% (0.02)

KEY STATISTICS

Market Cap$10.15 B
52w High$15.67
52w Low$11.36
Dividend Yield1.09%
FrequencyIrregular
P/E19.97
Volume1.67M
Shares Out.832.95M

COMPANY

LEADERSHIP

Erez Israeli
CHIEF EXECUTIVE
Erez Israeli

ABOUT

SECTOR
Healthcare
WENT PUBLIC
April 11, 2001
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
27,527

UPCOMING EARNINGS

DateOct 23, 2026
DayFriday
Rev. Est.$843.48M
OCT
23
FRI

SPLIT RECORD

DATETYPERATIO
2024-11-05Forward5:1
2006-09-07Forward2:1

PRICE

$12.18 ▲ UP 0.16% (+$0.02)
OVERLAYS
$12.12$12.16$12.209:34 AM10:38 AM11:42 AM12:47 PM1:51 PM2:55 PM3:59 PM12.18

About Dr. Reddy's Laboratories Limited

https://www.drreddys.com ↗

Dr. Reddy's Laboratories is a global integrated pharmaceutical company specializing in generics, active ingredients, proprietary formulations, and oncology, with operations in R&D, manufacturing, and contract services.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT DR. REDDY'S LABORATORIES LIMITED IS KNOWN FOR

Generic Semaglutide
Generic Semaglutide

Dr. Reddy's plans to launch a generic GLP-1 receptor agonist in India and Canada in early 2026, capitalizing on the growing market for type 2 diabetes and obesity treatments as patents for branded versions expire.

COMPETITORS

COMPETITOR
LLY COMPARE
NVO COMPARE
PFE COMPARE
TEVA COMPARE
VTRS COMPARE

Revenue by Geography

MapREGIONFY2023FY2024FY2025FY2026
Others Countries Country$67.47B $72.83B ▲$94.4B ▲$118.72B ▲
UNITED STATES— $135.56B $149.35B ▲$117.89B ▼
India Country$50.5B $48.47B ▼$55.83B ▲$64.54B ▲
Russia Country$21.23B $22.3B ▲$25.96B ▲$34.79B ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
62
LISTED HERE
14
RANKED BY POSITION SIZE
EMOP
2.18% · 3.7M
VWO
0.01% · 1.9M
AVEM
0.08% · 1.8M
SPEM
0.10% · 1.5M
DFEM
0.05% · 382.9K
EMEQ
0.27% · 139.9K
EELV
0.37% · 130.9K
JEMA
0.09% · 125.0K
APIE
0.08% · 75.6K
EDOG
2.21% · 54.6K
FNI
3.45% · 51.2K
NS
NSI
0.57% · 19.3K
SPWO
0.08% · 14.9K
BFLX
-0.07% · -111.0K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
11.59%
HOLDERS
377
TOP 12 OF 377 · RANKED BY POSITION SIZE
Robeco Institutional Asset Management B.V.
18.0M sh · $261.13M
Blackrock, Inc.
11.6M sh · $160.48M
Morgan Stanley
10.9M sh · $158.47M
Royal Bank Of Canada
10.2M sh · $142.07M
Renaissance Technologies LLC
8.8M sh · $122.78M
Aikya Investment Management Ltd
8.5M sh · $123.08M
Jpmorgan Chase & Co
6.0M sh · $84.27M
Dimensional Fund Advisors LP
5.4M sh · $75.22M
Vanguard Group Inc
5.1M sh · $71.63M
State Street Corp
4.2M sh · $58.13M
Bnp Paribas Arbitrage, Snc
4.2M sh · $58.3M
Alliancebernstein L.P.
3.7M sh · $51.67M

RATINGS SNAPSHOT

Overall rating: B+

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity4
Return On Assets4
Debt To Equity3
Price To Earnings1
Price To Book2
Overall Score3

INSIDER TRADES

★
OFFICER: GLOBAL HEAD OF QUALITY AND PV
MUNNIRPALLAM MADHU SUNDAR SUBRAMANIAN
— · —
2026-04-01
★
OFFICER: CHIEF FINANCIAL OFFICER
MANNAM VENKATA NARASIMHAM
— · —
2025-12-18
★
OFFICER: CEO - API AND SERVICES
SAPRA DEEPAK
— · —
2025-12-18
★
DIRECTOR:
Seth Alpna
— · —
2025-12-18

SECTORS PEERS

PEERPRICE
RVMD$207.88COMPARE
VTRS$16.34COMPARE
SOLV$91.12COMPARE
NBIX$154.06COMPARE
RVTY$128.80COMPARE
EXEL$54.45COMPARE
BMRN$64.67COMPARE
ELAN$24.11COMPARE